COVID-19 Research at BI

Refocusing Research Expertise and Accelerating New Collaborations

The members of the BI research community have refocused their research expertise to address the COVID-19 pandemic. Our researchers have pivoted their research projects and quickly formed new collaborations across campus and beyond to fight COVID-19 on many fronts. Below are some examples of active ongoing COVID-19 projects at BI.

The Shea group investitages antigen-conjugated nanoparticle treatment

Blood Coagulation and Fribinolysis

The Greineder Lab is studying the balance of coagulation and fibrinolysis in moderate-severe COVID-19 and to define its association with adverse clinical outcomes and abnormalities.

More about the Greineder Lab
A barrier-free environment

Single Cell Analysis of Immune Cells

The Keller Lab and the Single Cell Core are currently working with collaborators on B-cell antibody response post-COVID infection in patients using single cell analysis approaches.

More about the Single Cell Core
Lahann part of newly awarded NSF-ERC center

Synthetic Protein Nanoparticles

The Lahann Lab is designing synthetic protein nanoparticles (sPNP) to deliver vectored antibody transgenes encoding broadly neutralizing antibodies against SARS CoV-2.

More about the Lahann Lab
Moon receives two R01 awards from NIH

Vaccine Research

The Moon Lab is working on vaccines for inducing protective immune responses against COVID-19. We will perform animal studies to identify our lead candidates.

More about the Moon Lab
Evoq

Antibody Research

The Tessier Lab is currently working to define antibodies that potently recognize and neutralize the SARS-CoV-2 virus with the goal of accelerating therapeutic antibody and vaccine development.

More about the Tessier Lab

Chiral Nanoparticles

The Kotov Lab is investigating the applications of chiral nanoparticles and hedgehog particles for COVID-19 applications.

More about the Kotov Lab
Langmuir cover highlights research from Larson and Solomon

Infection Spread Modeling

The Larson Lab is working with collaborators to apply their expertise in modeling percolation processes on networks and model COVID-19 infection spread.

More about the Larson Lab
Nanotechnicum

Optical Sensor Platform

The Kim Lab has a well-established biosensor platform based on a conjugated polymer liposome system which produces color change and fluorescence development upon recognition of a target analyze. The sensory platform is readily available for modification and optimization for COVID19 detection.

More about the Kim Lab

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us